Latest News about Genentech
Recent news which mentions Genentech
From Business Journals
From Business Journals
Genentech gets nod for big South San Francisco expansion plans
November 25, 2020
From Business Journals
Vacaville creates ‘fast track’ program as part of push for more biotech
November 23, 2020
From Business Journals
Resilience raises over $800 million to transform pharmaceutical manufacturing in response to COVID-19
November 23, 2020
Tickers
TC
From TechCrunch
Targeting Parkinson's, Peninsula drug maker nabs $60M to continue Roche partnership
October 21, 2020
From Business Journals
From Business Journals
From Benzinga
Why Shares Of Small-Cap Biopharma AC Immune Are Plunging
September 23, 2020
From Benzinga
Promising gene therapy against hemophilia rejected by FDA
August 19, 2020
From Business Journals
Genentech takes on 2 competitors with new rare eye disease drug
August 17, 2020
From Business Journals
From Business Journals
Genentech's latest drug is a big — and expensive — option against muscle-wasting disease
August 07, 2020
From Business Journals
Denali shares soar on potential $2.4 billion Parkinson's, Alzheimer's deal with Biogen
August 06, 2020
From Business Journals
Genentech eliminates nearly 500 jobs
July 29, 2020
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Backed by $700M, startup led by vets of Genentech, UCSF, Juno has ambitious cell and gene therapy goals
June 24, 2020
From Business Journals
From Business Journals
From Business Journals
Will anything come of AstraZeneca's rumored interest in merging with Gilead? Not likely
June 08, 2020
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.